Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TMVR with transfemoral access a 'promising option' | Big acquisition news for Philips | More from TCT 2021
Tuesday, November 9, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TMVR with transfemoral access a 'promising option,’ early data suggest

Researchers reported at TCT 2021 that survival was 100% after 30 days.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TMVR with transfemoral access a 'promising option,’ early data suggest

Share on Twitter Share on Facebook Share on Linkedin
Researchers reported at TCT 2021 that survival was 100% after 30 days.
READ MORE >

Philips enters agreement to acquire Cardiologs

Cardiologs, known for its AI- and cloud-based cardiac solutions, will soon be a part of the Philips family. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Philips enters agreement to acquire Cardiologs

Share on Twitter Share on Facebook Share on Linkedin
Cardiologs, known for its AI- and cloud-based cardiac solutions, will soon be a part of the Philips family. 
READ MORE >

Some cancer immunotherapies may increase the risk of myocarditis

The study's authors tracked data from facilities in 11 different countries, examining imaging findings from patients with ICI-related myocarditis. 

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

Some cancer immunotherapies may increase the risk of myocarditis

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
The study's authors tracked data from facilities in 11 different countries, examining imaging findings from patients with ICI-related myocarditis. 
READ MORE >

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021. 

READ MORE >
Patient
Share on Twitter Share on Facebook Share on Linkedin

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

Share on Twitter Share on Facebook Share on Linkedin
Patient
The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021. 
READ MORE >

Early epinephrine treatment during cardiac arrest increases chance of a good recovery

Patients who received epinephrine within four minutes after the first shock from an AED had a better chance of recovery.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Early epinephrine treatment during cardiac arrest increases chance of a good recovery

Share on Twitter Share on Facebook Share on Linkedin
Patients who received epinephrine within four minutes after the first shock from an AED had a better chance of recovery.
READ MORE >

Tracking sac regression after endovascular aneurysm repair for AAA

Researchers pointed to the importance of tracking long-term patient outcomes related to EVAR for AAA. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Tracking sac regression after endovascular aneurysm repair for AAA

Share on Twitter Share on Facebook Share on Linkedin
Researchers pointed to the importance of tracking long-term patient outcomes related to EVAR for AAA. 
READ MORE >

Featured Articles

Ohio State cardiologists first in US to perform new heart failure treatment—patient feels ‘100% better’

The procedure, performed as part of a clinical trial, appears to have been a complete success. 

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Ohio State cardiologists first in US to perform new heart failure treatment—patient feels ‘100% better’

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
The procedure, performed as part of a clinical trial, appears to have been a complete success. 
READ MORE >

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 

READ MORE >
Old doctor
Share on Twitter Share on Facebook Share on Linkedin

5 years later, TAVR still delivering strong results for intermediate-risk patients

Share on Twitter Share on Facebook Share on Linkedin
Old doctor
Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 
READ MORE >

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

Share on Twitter Share on Facebook Share on Linkedin
heart.png
The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.
READ MORE >

Icosapent ethyl lowers risk of ischemic events in CABG patients

Researchers examined data from CABG patients who participated in the REDUCE-IT trial. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Icosapent ethyl lowers risk of ischemic events in CABG patients

Share on Twitter Share on Facebook Share on Linkedin
Researchers examined data from CABG patients who participated in the REDUCE-IT trial. 
READ MORE >

In Other News

American College of Radiology contemplating legal action to halt provision in surprise billing law

The Texas Medical Association already filed suit against the Biden administration late last month, and ACR said the suit echoes several of its concerns. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American College of Radiology contemplating legal action to halt provision in surprise billing law

Share on Twitter Share on Facebook Share on Linkedin
The Texas Medical Association already filed suit against the Biden administration late last month, and ACR said the suit echoes several of its concerns. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme